Stocktoria

CALLAN JMB INC. CJMB

Nasdaq · stock · Services-Business Services, NEC · website · IPO 2025-02-05

CALLAN JMB INC. (CJMB) earns a Piotroski F-score of 1/9 (weak financial health), with an Altman Z″ in the distress zone. It pays a dividend (safety: no dividend). FY2025 revenue was $5.7M at a -139.2% net margin.

Chart by TradingView
9/100
Stocktoria Quality Score · grade D
1/9
Piotroski F — financial health
-11.4
Altman Z″ — distress risk · distress
Dividend yield · no dividend

Quality score trend · recomputed for each fiscal year

Piotroski F /9
2 1 20242025
Altman Z″
-0.09 -11.40 20242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$2.19 as of 2026-08-12 · -55.1% 1y
$0.73$4.8852-wk
Market cap USD$4M
Net margin 5y avg-52.5%
Return on equity 5y avg-129.9%
Employees18
Revenue trend · last 3y · down

How it ranks in Services · percentile among 982 companies

Piotroski Fstronger than 1%
Net marginstronger than 15%
Return on equitystronger than 3%

Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 1/9 tests passed

Altman Z″ components · distress zone

ComponentValue
Working capital / assets0.285
Retained earnings / assets-1.776
EBIT / assets-1.218
Equity / liabilities0.675

Sector peers · similar-size Services companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
CJMBCALLAN JMB INC.1/9-11.4
ASFHASIAFIN HOLDINGS CORP.4/9-1.75
FRQNFrequency Holdings, Inc5/9
FTFTFuture FinTech Group Inc.3/9-7.78
WAITop KingWin Ltd3/98.42
XHLDTEN Holdings, Inc.2/9-11.06
MIMIMint Inc Ltd1/97.25

All Services companies →

About CALLAN JMB INC.

Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides emergency preparedness services, which includes managing their building sites, medical stockpiles of equipment, and supplies and responding to state or local emergencies; specialty temperature-regulating packaging; technical services; and advanced monitoring sentry technology. The company was founded in 2006 and is headquartered in Spring Branch, Texas.

FAQ

Is CJMB financially healthy?

CALLAN JMB INC.'s Piotroski F-score is 1/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does CJMB pay a dividend, and is it safe?

Yes. CALLAN JMB INC. pays a dividend with a None payout ratio, rated “no dividend” for safety.

How profitable is CJMB?

In FY2025, CALLAN JMB INC. had a net margin of -139.2% and a return on equity of -342.2%.

Is CJMB a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on CALLAN JMB INC.: a Piotroski F-score of 1/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.